Author:
Panés J.,Bouzas R.,Chaparro M.,García-Sánchez V.,Gisbert J. P.,Martínez de Guereñu B.,Mendoza J. L.,Paredes J. M.,Quiroga S.,Ripollés T.,Rimola J.
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Reference74 articles.
1. Infliximab, azathioprine, or combination therapy for Crohn’s disease;Colombel;N Engl J Med,2010
2. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet,2002
3. A randomized, double-blind, controlled withdrawal trial in Crohn’s disease patients in long-term remission on azathioprine;Lemann;Gastroenterology,2005
4. Long term outcome of patients with active Crohn’s disease exhibiting extensive and deep ulcerations at colonoscopy;Allez;Am J Gastroenterol,2002
5. Mural attenuation in normal small bowel and active inflammatory Crohn’s disease on CT enterography: location, absolute attenuation, relative attenuation, and the effect of wall thickness;Baker;AJR Am J Roentgenol,2009
Cited by
544 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献